HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Immunomodulatory effects of intravenous immunoglobulins].

Abstract
Intravenous immunoglobulin (IVIg) has been used for many years in the treatment of primary and secondary antibody deficiencies. IVIg was first demonstrated to be effective in auto-immune desorders twenty years ago in the treatment of idiopathic thrombocytopenic purpura. The beneficial effect of IVIg has since been established in the Guillain-Barré syndrome, chronic inflammatory demenilating polyneuropathy, myasthenia gravis, dermatomyositis, Kawasaki syndrome and graft versus host disease. The beneficial effect of IVIg has been suggested in a large number of other auto-immune and systemic inflammatory conditions. The mode of action of IVIg is complex, involving Fc receptor blockade, interference with complement activation and the cytokine network, provision of anti-idiotypic antibodies and modulation of T and B cell activation and differentiation. Such a broad range of activities reflects the function of normal circulating immunoglobulins in maintaining tolerance to self in healthy individuals.
AuthorsM Kazatchkine, L Mouthon, S V Kaveri
JournalAnnales de meĢdecine interne (Ann Med Interne (Paris)) Vol. 151 Suppl 1 Pg. 1S13-8 (May 2000) ISSN: 0003-410X [Print] FRANCE
Vernacular TitleEffets immunomodulateurs des immunoglobulines intraveineuses.
PMID10896983 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Adjuvants, Immunologic
  • Antibodies, Anti-Idiotypic
  • Cytokines
  • Immunoglobulins, Intravenous
  • Receptors, Fc
Topics
  • Adjuvants, Immunologic (therapeutic use)
  • Antibodies, Anti-Idiotypic (therapeutic use)
  • Autoimmune Diseases (therapy)
  • Complement Activation (immunology)
  • Cytokines (immunology)
  • Humans
  • Immunoglobulins, Intravenous (therapeutic use)
  • Immunologic Deficiency Syndromes (therapy)
  • Lymphocyte Activation (immunology)
  • Polyneuropathies (therapy)
  • Receptors, Fc (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: